Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Zhengye Biotechnology Holding Limited (ZYBT) had Cash Flow from Financial Activities of $4.62M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$19.65M |
|
$52.71M |
|
$61.54M |
|
$62.41M |
|
$17.23M |
|
$1.27M |
|
$1.28M |
|
$18.56M |
|
$43.85M |
|
$36.02M |
|
$43.85M |
|
-- |
|
| Cash Flow Statement Financials | |
$1.91M |
|
$-1.81M |
|
|
Cash Flow from Financial Activities |
$4.62M |
$2.66M |
|
$7.20M |
|
$4.54M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|